tinidazole has been researched along with norfloxacin in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Desai, HG; Gill, HH; Kalro, RH; Mehta, PR; Murti, PK; Prabhu, SR; Ranganathan, S | 1 |
El-Anwar, FM; El-Moghazy Aly, SM; Mohammad, MA; Zawilla, NH | 1 |
Helmy, SA | 1 |
Abou-Taleb, NH; El-Ashry, SM; El-Sherbiny, DT; El-Wasseef, DR | 1 |
Abdelaleem, EA; Ali, NW; Hassan, ES; Naguib, IA | 1 |
Hemdan Abou-Taleb, N; Ibrahim El-Subbagh, H; Mahmoud El-Enany, N; Tawfik El-Sherbiny, D | 1 |
Abdelaleem, EA; Ali, NW; Gamal, M; Hassan, ES; Naguib, IA | 1 |
1 review(s) available for tinidazole and norfloxacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for tinidazole and norfloxacin
Article | Year |
---|---|
Mono and dual therapy for Helicobacter pylori associated gastritis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Norfloxacin; Organometallic Compounds; Tinidazole | 1991 |
9 other study(ies) available for tinidazole and norfloxacin
Article | Year |
---|---|
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Stability indicating methods for the determination of norfloxacin in mixture with tinidazole.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Densitometry; Drug Stability; Norfloxacin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tinidazole | 2007 |
Simultaneous quantification of linezolid, tinidazole, norfloxacin, moxifloxacin, levofloxacin, and gatifloxacin in human plasma for therapeutic drug monitoring and pharmacokinetic studies in human volunteers.
Topics: Acetamides; Adult; Anti-Infective Agents; Aza Compounds; Chromatography, High Pressure Liquid; Drug Monitoring; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Limit of Detection; Linezolid; Male; Moxifloxacin; Norfloxacin; Oxazolidinones; Quinolines; Reproducibility of Results; Sensitivity and Specificity; Tinidazole; Young Adult | 2013 |
Multiobjective optimization strategy based on desirability functions used for the microemulsion liquid chromatographic separation and quantification of norfloxacin and tinidazole in plasma and formulations.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Emulsions; Humans; Norfloxacin; Plasma; Tinidazole | 2015 |
HPTLC method for Simultaneous Determination of Norfloxacin and Tinidazole in presence of Tinidazole Impurity.
Topics: Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Contamination; Limit of Detection; Linear Models; Norfloxacin; Reproducibility of Results; Tinidazole | 2019 |
Digitally enhanced thin layer chromatography for simultaneous determination of norfloxacin and tinidazole with the aid of Taguchi orthogonal array and desirability function approach: Greenness assessment by analytical Eco-Scale.
Topics: Chromatography, Thin Layer; Mobile Applications; Norfloxacin; Tinidazole; Trifluoroacetic Acid | 2020 |
Partial least squares and linear support vector regression chemometric models for analysis of Norfloxacin and Tinidazole with Tinidazole impurity.
Topics: Calibration; Least-Squares Analysis; Linear Models; Norfloxacin; Tinidazole | 2020 |